MINDACT (Microarray In Node-negative Disease may Avoid Chemotherapy): a prospective, randomised study comparing the 70-gene signature with the common clinical-pathological criteria in selecting patients for adjuvant chemotherapy in node-negative breast cancer

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2008
This article has no abstract
Epistemonikos ID: c5e3ef31c73b09deaf0e6a92e6ae6f2e3d64bab7
First added on: Jan 17, 2025